ISPE Launches New Community for Radiopharmaceutical Specialists
The International Society for Pharmaceutical Engineering (ISPE) has introduced a new initiative, the ISPE Radiopharmaceuticals Community of Practice (CoP). This community aims to cater to the rapid advancements and unique challenges present in the radiopharmaceuticals sector, which is increasingly essential in precision medicine, particularly for conditions like cancer.
Understanding the Radiopharmaceuticals Community of Practice
With this new CoP, ISPE seeks to create a dedicated space for professionals engaged in radiopharmaceutical development and expertise. As Jason Tang, Chair and Founder of this CoP, notes, "The complexities associated with radiopharmaceuticals, including the management of radioactive isotopes and regulatory compliance, significantly differ from traditional pharmaceuticals." He emphasizes that these complexities affect everything, from R&D and manufacturing to global logistics and quality assurance.
Key Figures in the Community
Joining Jason Tang in this venture are Michele Ghinizzini, Co-Chair and Senior Vice President at Sanofi, and Alexander Prather, Secretary and Senior Principal Mechanical Engineer at Cardinal Health. Together, they will lead the community's efforts and support its mission:
Mission and Objectives of the CoP
The Radiopharmaceuticals CoP aims to address specific challenges encountered in the industry. Key objectives include:
- Creating a network for experts in the radiopharmaceutical field.
- Facilitating problem-solving and networking among members.
- Fostering innovation and knowledge sharing to improve practices.
- Disseminating best practices and new ideas through ISPE resources.
- Creating a dialogue between industry players and regulatory authorities to better navigate compliance.
Technical Focus Areas of the Community
Focusing on the entire lifecycle of radiopharmaceuticals, the CoP’s technical pillars encompass:
- Radiopharmaceutical engineering: Emphasizing manufacturing process design and equipment lifecycle management.
- Production and manufacturing: Addressing isotope production, formulation, and GMP.
- Quality assurance: Maintaining regulatory compliance and risk management.
- Supply chain management: Discussing logistics for short-lived isotopes and waste management.
- Research and development: Focusing on novel therapies, imaging agents, and clinical trials.
- Safety protocols: Ensuring emergency preparedness and dosimetry.
- Education and training: Promoting workforce development and partnerships with educational institutions.
- Sustainability initiatives: Exploring green chemistry and resource optimization.
- Technology transfer: Enhancing collaboration and knowledge sharing.
Collaboration Across ISPE Communities
Members of the Radiopharmaceuticals CoP will collaborate not only within their group but also with other ISPE communities. This includes partnerships with CoPs focusing on biotechnology, critical utilities, and sterile product processing. Such collaborative efforts will help provide comprehensive guidance and solutions for the radiopharmaceutical sector.
Joining the Radiopharmaceuticals CoP
Members of ISPE interested in this new community can join by selecting the Radiopharmaceuticals CoP within their profiles. For a complete overview of existing CoPs, ISPE members can access the organization’s resources online. Those looking to become members of ISPE can find relevant information on the ISPE website.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global organization dedicated to advancing the pharmaceutical industry through scientific and regulatory knowledge. With over 25,000 members across more than 120 countries, ISPE offers solutions to complex challenges in pharmaceutical engineering. It has established its headquarters and training center in Maryland, with a regional operations center in Florida. To learn more about ISPE, professionals can explore various resources available on their website.
Frequently Asked Questions
What is the purpose of the ISPE Radiopharmaceuticals CoP?
The CoP aims to address unique challenges in the radiopharmaceutical field and foster innovation among industry professionals.
Who are the leaders of the Radiopharmaceuticals CoP?
Jason Tang serves as Chair, while Michele Ghinizzini and Alexander Prather are Co-Chair and Secretary, respectively.
What are the technical pillars of the community?
The CoP focuses on engineering, manufacturing, quality assurance, supply chain, research, safety, and education related to radiopharmaceuticals.
How can ISPE members join the Radiopharmaceuticals CoP?
Members can join by selecting the CoP option in their ISPE profile online.
What is ISPE's role in the pharmaceutical industry?
ISPE provides technical and regulatory support, resources, and a global network for its members to tackle industry challenges effectively.
